US Stock Market Move | Regencell Bioscience Holdings Ltd. (RGC.US) has risen by more than 47%, and has risen by more than 6246% since the beginning of the year.
As of press time, the stock has risen more than 47%, reporting at $313.54.
On Friday, the stock price of Regencell Bioscience Holdings Ltd. (RGC.US) soared, reaching $313.54 by the time of publication, an increase of over 47%. The stock has risen over 6246% year-to-date. Regencell Bioscience Holdings Ltd. is an early-stage biotechnology company focused on the research and commercialization of traditional Chinese medicine for the treatment of neurocognitive disorders and degenerative changes, specifically ADHD and ASD.
RECOMMEND
National Bureau of Statistics: In April 2025, the year-on-year decrease in the producer prices of industrial products at the factory was 2.7%.
10/05/2025
People's Daily Bell: It is not realistic to expect to solve problems with just one or two negotiations.
10/05/2025
U.S. Treasury Secretary warns that special measures to prevent the federal government from reaching its debt limit may be exhausted by August, urging Congress to take action as soon as possible.
10/05/2025
